6BFQ
The mechanism of GM-CSF inhibition by human GM-CSF auto-antibodies
Experimental procedure
| Experimental method | SINGLE WAVELENGTH |
| Source type | SYNCHROTRON |
| Source details | AUSTRALIAN SYNCHROTRON BEAMLINE MX2 |
| Synchrotron site | Australian Synchrotron |
| Beamline | MX2 |
| Temperature [K] | 100 |
| Detector technology | CCD |
| Collection date | 2014-07-08 |
| Detector | ADSC QUANTUM 315r |
| Wavelength(s) | 0.954 |
| Spacegroup name | P 1 |
| Unit cell lengths | 95.437, 100.535, 101.866 |
| Unit cell angles | 91.17, 117.96, 108.65 |
Refinement procedure
| Resolution | 50.010 - 2.600 |
| R-factor | 0.232 |
| Rwork | 0.230 |
| R-free | 0.26440 |
| Structure solution method | MOLECULAR REPLACEMENT |
| Starting model (for MR) | 2jix |
| RMSD bond length | 0.014 |
| RMSD bond angle | 1.675 |
| Data reduction software | XDS |
| Data scaling software | Aimless (0.5.4) |
| Phasing software | MOLREP |
| Refinement software | REFMAC (5.8.0158) |
Data quality characteristics
| Overall | Inner shell | Outer shell | |
| Low resolution limit [Å] | 50.010 | 46.630 | 2.640 |
| High resolution limit [Å] | 2.600 | 14.220 | 2.600 |
| Rmerge | 0.246 | 0.097 | |
| Rmeas | 0.281 | 0.110 | |
| Rpim | 0.134 | 0.051 | 0.828 |
| Number of reflections | 94668 | 553 | 4471 |
| <I/σ(I)> | 39 | ||
| Completeness [%] | 98.7 | 95.7 | 93.4 |
| Redundancy | 4.1 | 4.4 | 2.7 |
| CC(1/2) | 0.967 | 0.990 | 0.344 |
Crystallization Conditions
| crystal ID | method | pH | temperature | details |
| 1 | VAPOR DIFFUSION, HANGING DROP | 283.15 | 0.16 M Calcium acetate, 14.4% PEG8000, 0.08 M Sodium Cacodylate pH 6.5 and 20% glycerol |






